SA author is super pumper, he argues through comments...
Anavex will likely present and publish in a peer-reviewed journal the Phase 2b/3 data in Q1 2023. Emergency approval by the FDA could come in Q2 2023. I am thinking as early as May.
This "Political Economist" doesn't know how Misleading works, peer review by Q1 2023, may be he has typo, he means 2032....